Insmed Incorporated Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
AGIO
Agios Pharmaceuticals, Inc. |
$33.31 | $2.70 B | -7.55 | 383 | $26.82 M |
AKRO
Akero Therapeutics, Inc. |
$21.86 | $1.59 B | -7.1 | 60 | $0 |
APLS
Apellis Pharmaceuticals, Inc. |
$27.66 | $4.90 B | -11.77 | 702 | $396.59 M |
ASND
Ascendis Pharma A/S |
$131.98 | $7.77 B | -14.19 | 879 | $266.72 M |
BGNE
BeiGene, Ltd. |
$184.71 | $17.07 B | -20.76 | 10600 | $2.46 B |
BPMC
Blueprint Medicines Corporation |
$102.54 | $6.47 B | -21.48 | 638 | $249.38 M |
CERE
Cerevel Therapeutics Holdings, Inc. |
$44.96 | $7.29 B | -14.66 | 355 | $0 |
DAWN
Day One Biopharmaceuticals, Inc. |
$11.15 | $1.12 B | -5.11 | 174 | $0 |
EWTX
Edgewise Therapeutics, Inc. |
$27.51 | $1.65 B | -11.47 | 108 | $0 |
FENC
Fennec Pharmaceuticals Inc. |
$5.62 | $187.43 M | 171.5 | 29 | $21.25 M |
HALO
Halozyme Therapeutics, Inc. |
$53.83 | $6.47 B | 21.1 | 373 | $829.25 M |
HRMY
Harmony Biosciences Holdings, Inc. |
$36.40 | $1.73 B | 13.15 | 246 | $582.02 M |
JANX
Janux Therapeutics, Inc. |
$45.37 | $2.29 B | -36.8 | 76 | $8.08 M |
KROS
Keros Therapeutics, Inc. |
$12.48 | $1.76 B | -9.45 | 160 | $151,000 |
RARE
Ultragenyx Pharmaceutical Inc. |
$39.99 | $3.44 B | -5.21 | 1276 | $434.25 M |
RNA
Avidity Biosciences, Inc. |
$27.03 | $2.54 B | -8.99 | 253 | $9.56 M |
RVMD
Revolution Medicines, Inc. |
$39.79 | $6.66 B | -10.51 | 490 | $11.58 M |
SWTX
SpringWorks Therapeutics, Inc. |
$32.49 | $2.98 B | -7.81 | 305 | $5.45 M |